Skip to main content
Livermore
Livermore
ZHEN

Journey Advisory Group, LLC

SEC CIK
0001840085
Latest filing
Aug 4, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by Journey Advisory Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
2,516
Value
$227.6K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of EW by Journey Advisory Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,516$227.6K<0.1%−184−6.8%ReducedHolders
Q1 20262,700$216.2K<0.1%+34+1.3%AddedHolders
Q4 20252,666$227.3K<0.1%00.0%UnchangedHolders
Q3 20252,666$207.3K<0.1%−990−27.1%ReducedHolders
Q2 20253,656$285.9K<0.1%−1,039−22.1%ReducedHolders
Q1 20254,695$340.3K<0.1%+4,695NewHolders
Q4 20240$00.0%−5,040−100.0%Sold outHolders
Q3 20245,040$465.5K0.1%00.0%UnchangedHolders
Q2 20245,040$465.5K0.1%−3,799−43.0%ReducedHolders
Q1 20248,839$844.7K0.1%−3,455−28.1%ReducedHolders
Q4 202312,294$937.4K0.1%−750−5.7%ReducedHolders
Q3 202313,044$903.7K0.1%−1,525−10.5%ReducedHolders
Q2 202314,569$1.37M0.2%−2,810−16.2%ReducedHolders
Q1 202317,379$1.44M0.2%−5,810−25.1%ReducedHolders
Q4 202223,189$1.73M0.4%−2,825−10.9%ReducedHolders
Q3 202226,014$2.15M0.5%+300+1.2%AddedHolders
Q2 202225,714$2.56M0.6%−2,070−7.5%ReducedHolders
Q1 202227,784$3.27M0.8%00.0%UnchangedHolders
Q4 202127,784$3.60M1.0%00.0%UnchangedHolders
Q3 202127,784$3.15M1.0%−1,465−5.0%ReducedHolders
Q2 202129,249$3.03M1.0%−90−0.3%ReducedHolders
Q1 202129,339$2.45M0.9%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.